Navigation Links
New cancer drug shows promise for treating advanced melanoma
Date:6/2/2013

Researchers from UCLA's Jonsson Comprehensive Cancer Center report that a new drug in preliminary tests has shown promising results with very manageable side effects for treating patients with melanoma, the deadliest form of skin cancer.

The results were presented at the 2013 meeting of the American Society of Clinical Oncology today in Chicago by Dr. Antoni Ribas, professor of medicine in the UCLA division of hematology-oncology, who led the research. Following Ribas' presentation, the study was published online ahead of press in the New England Journal of Medicine.

The results are from the first clinical trial of the drug lambrolizumab (MK3475), which was discovered and developed by Merck. Researchers analyzed 135 patients with advanced metastatic melanoma who were divided into three groups with different treatment regimens.

Overall, 38 percent of patients taking lambrolizumab saw confirmed improvement of their cancer across all dose levels. Of those taking the lowest dose of lambrolizumab, 25 percent showed improvement, while 52 percent of those who received the highest dose improved. The rate of any tumor response across all patients was 77 percent. Researchers have not yet determined the average duration of response to the drug, because only five patients who had initial responses were taken off the study after their cancers got worse. To date, the longest response has been over one year.

Side effects with lambrolizumab are usually mild and easily managed. These include fatigue, fever, skin rash, loss of skin color and muscle weakness. Thirteen percent of patients had side effects that were more severe, including inflammation of the lung or kidney, and thyroid problems.

"This study is showing the highest rate of durable melanoma responses of any drug we have tested thus far for melanoma, and it is doing it without serious side effects in the great majority of patients," Ribas said.

'/>"/>
Contact: Shaun Mason
smason@mednet.ucla.edu
University of California - Los Angeles
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Some patients with treatment-resistant colorectal cancers may have a new option
2. Abnormalities in HER2 gene found in wide variety of advanced cancers
3. New Drug May Slow Advanced Ovarian Cancer
4. Doubling Time on Tamoxifen Cuts Odds for Breast Cancers Return: Study
5. MGH-led studies shed new light on targeted lung cancer therapy
6. No increased risk of infection for long-term sex partners of people with HPV-related oral cancers
7. Likelihood of Spousal HPV Oral Infection, Predictors of Melanoma and Throat Cancer, Preventing Cancer Readmissions
8. Spousal oral HPV, predictors of melanoma and throat cancer, preventing cancer readmissions
9. New drug improves progression-free survival, shrinks tumors in rare cancer for first time
10. Voices Against Brain Cancer Comments on New Potential Development in Brain Cancer Treatment
11. National Camp Series (NCS) Associate Chris Husby Joins Kicking For The Dream’s Effort to Fight Ovarian Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... ... June 30, 2015 , ... Some may define success as the sum ... of New York State Athletic Trainers’ Association (NYSATA) and its members continue to be ... national awards, and a number of members also received honors at the national level. ...
(Date:6/30/2015)... Atlanta, GA (PRWEB) , ... June 30, 2015 ... ... and achievements of aspiring data scientists and analysts who are currently attending an ... Analytics, the growth of data has provided new insight into healthcare, the environment, ...
(Date:6/30/2015)... ... June 30, 2015 , ... Curly Hair Solutions™ is honoured ... beauty event in the US, featuring products from all over the world. For the ... Collection is a line of hair styling products focused entirely on meeting the needs ...
(Date:6/29/2015)... ... 2015 , ... Aespala Medspa and Plastic Surgery is proud to introduce the ... , Dr. Dreyfuss received his medical degree from Emory University in Atlanta before completing ... Surgery Fellowship at the University of Chicago. He has taught and practiced medicine in ...
(Date:6/29/2015)... , ... June 30, 2015 , ... ... has released a new website intended for executives and administrators with hospitals, healthcare ... experience, and the final product is a result of comprehensive research and implementation ...
Breaking Medicine News(10 mins):Health News:NYSATA and Members Recognized with National Awards 2Health News:NYSATA and Members Recognized with National Awards 3Health News:Izenda Offers Embedded BI and Analytics Scholarship 2Health News:Izenda Offers Embedded BI and Analytics Scholarship 3Health News:Curly Hair Solutions™ Showcases Entire Curl Keeper™ Collection at Cosmoprof Las Vegas July 12 - 14 2Health News:Aespala Medspa and Plastic Surgery Welcomes New Plastic Surgeon to Oak Brook, IL Office 2Health News:Aespala Medspa and Plastic Surgery Welcomes New Plastic Surgeon to Oak Brook, IL Office 3Health News:Career Step Launches New Website to Better Meet Needs of Partners, Clients and Others Searching for Corporate Training Solutions 2
... and exposed mainly to sign language use their hands ... important precursor to learning a language. , Dr. ... & Brain Sciences and Education at Dartmouth College in ... key that lets them unlock the secret of their ...
... alcohol affects the brain in elderly people was carried out ... were investigated to discover the link between drinking and the ... really a double-edged sword.// ,It has been found ... has a negative impact on brain function. But light-to-moderate drinkers ...
... the Institute for the Study of Aging and the International ... agile are better advised to put down the pill bottle ... seniors who do crossword puzzles, exercise and seek help for ... their trust in unproven cures such as melatonin, DHEA, testosterone ...
... Pharmaceutical Industries entered the antismoking segment with its "Smoquit" ... been used for over a decade as an antidepressant, ... priced Smoquit, the first pharmacotherapy ever available for the ... is required to be taken under medical supervision and ...
... produced strong evidence that passive smoking has a lasting ... ,A team from the US National Center for Environmental ... 3 to 16 years. ,The researchers analysed ... substance called cotinine, produced when the body breaks down ...
... paltry number of human genes more than 30 per cent ... human genome sequence seemed scanty compared with the mustard weeds' ... the Genomics Institute of the Novartis Research Foundation in San ... they overlap only by about half.// ,The researchers detect ...
Cached Medicine News:
(Date:6/29/2015)... June 30, 2015 Mordor Intelligence presents ... Primary Packaging Material (Plastic, Glass, Paper, Metal) - ByType of ... Pouches, Syringes, Tubes, Vials, Sachets) - By Geographical Region ( ... Asia Pacific , Latin America ... Africa ) - discussing Industry Value Chain Analysis, ...
(Date:6/29/2015)... PARK, Calif. , June 29, 2015  Nevro ... company that is providing innovative evidence-based solutions for the ... Earnhardt , President and Chief Executive Officer of Intersect ... its Board of Directors, effective June 28, 2015. ... Earnhardt has successfully led Intersect ENT, a company ...
(Date:6/29/2015)... 2015 DURECT Corporation (Nasdaq: DRRX ... , President and CEO, will be presenting at ... 8 at 11:45 a.m. Eastern Time.  The conference ... in New York City.  Investors and analysts that ... meeting through the conference organizers at http://www.cantorconferences.com/health-registration/health-investors ...
Breaking Medicine Technology:Global Pharmaceutical Packaging Market - North America and Europe Expected to Lead Followed by the Asia Pacific Market 2Global Pharmaceutical Packaging Market - North America and Europe Expected to Lead Followed by the Asia Pacific Market 3Nevro Appoints Lisa Earnhardt to its Board of Directors 2DURECT to Present at the Cantor Fitzgerald Healthcare Conference 2
... 14, 2011 /PRNewswire-iReach/ --   Olympus America ... collection of EZ Shot 2 single-use aspiration needles for ... puncture capability along with an adjustable sheath designed to ... in a complete selection of sizes and styles, the ...
... Specialty Pharmacy, the nation,s largest, privately owned specialty ... healthcare and specialty pharmacy executive, has joined Diplomat,s ... as an industry executive in pharma, prescription benefit ... the perfect fit to help drive Diplomat,s continued ...
Cached Medicine Technology:Olympus Broadens Portfolio With a Suite of New Single-Use Aspiration Needles 2Veteran Healthcare and Pharmacy Executive Craig Stephens Joins Diplomat Specialty Pharmacy as Group Vice President of Business Development and Trade Relations 2
... Utilizing breakthrough electro-optical and rotary ... SUPRA is capable of obtaining ... pupils as narrow as 2.0mm. ... precise diagnostic results when dealing ...
Sterile perfluorocarbon for intraocular Application....
Sterile Silicone Oil for Intraocular Application....
Highly concentrated daily cleaner with Microclens beads for superior cleaning action....
Medicine Products: